A mutation in the signal transducer and the activator of the transcription 3 (STAT3) gene has been identified in the majority of AD-HIES patients, which results in impaired Th17 cell differentiation and downregulation of antimicrobial responses (50–55). Here, STAT3 is linked to Alzheimer disease.